There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acadia Healthcare (ACHC – Research Report) and Teva Pharmaceutical (TEVA – Research Report) with bullish sentiments.
Acadia Healthcare (ACHC)
In a report released today, John Ransom from Raymond James maintained a Buy rating on Acadia Healthcare. The company’s shares closed last Friday at $61.56, close to its 52-week high of $68.00.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of
Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $67.67, which is an 8.9% upside from current levels. In a report issued on June 10, RBC Capital also maintained a Buy rating on the stock with a $74.00 price target.
See today’s analyst top recommended stocks >>
Teva Pharmaceutical (TEVA)
In a report released today, Elliot Wilbur from Raymond James initiated coverage with a Buy rating on Teva Pharmaceutical. The company’s shares closed last Friday at $10.12.
According to TipRanks.com, Wilbur has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Teva Pharmaceutical with a $11.33 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.